17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A semi-invariant V α10 + T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen–recognition properties

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Type I natural killer T cells (NKT cells) are characterized by an invariant variable region 14–joining region 18 (V α14-V α18) T cell antigen receptor (TCR) α-chain and recognition of the glycolipid α-galactosylceramide (α-GalCer) restricted to the antigen-presenting molecule CD1d. Here we describe a population of α-GalCer-reactive NKT cells that expressed a canonical V α10-J α50 TCR α-chain, which showed a preference for α-glucosylceramide (α-GlcCer) and bacterial α-glucuronic acid–containing glycolipid antigens. Structurally, despite very limited TCRα sequence identity, the V α10 TCR–CD1d–α-GlcCer complex had a docking mode similar to that of type I TCR–CD1d–α-GalCer complexes, although differences at the antigen-binding interface accounted for the altered antigen specificity. Our findings provide new insight into the structural basis and evolution of glycolipid antigen recognition and have notable implications for the scope and immunological role of glycolipid-specific T cell responses.

          Related collections

          Author and article information

          Journal
          100941354
          21750
          Nat Immunol
          Nat. Immunol.
          Nature immunology
          1529-2908
          1529-2916
          15 August 2017
          12 June 2011
          12 June 2011
          05 September 2017
          : 12
          : 7
          : 616-623
          Affiliations
          [1 ]Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia
          [2 ]ARC Centre of Excellence in Structural and Functional Microbial Genomics, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia
          [3 ]School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia
          [4 ]School of Biosciences, University of Birmingham, Edgbaston, Birmingham, UK
          [5 ]Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA
          [6 ]Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
          Author notes
          Correspondence should be addressed to J.R. ( jamie.rossjohn@ 123456monash.edu ) or D.I.G. ( godfrey@ 123456unimelb.edu.au )
          [7]

          These authors contributed equally to this work.

          Article
          PMC5584938 PMC5584938 5584938 nihpa899452
          10.1038/ni.2051
          5584938
          21666690
          c35d720f-fc3c-4d7f-bbfb-1b0be33edc88
          History
          Categories
          Article

          Comments

          Comment on this article